Former FDA Officials Say Fosamax Claims Aren't Barred
Former U.S. Food and Drug Administration officials told the Third Circuit if it rules that patients' claims that Merck failed to warn that its osteoporosis drug Fosamax caused certain fractures are...To view the full article, register now.
Already a subscriber? Click here to view full article